(Q53349400)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

A sensitive aβ oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

0 references

Mary J Savage

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Juliya Kalinina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Abigail Wolfe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Katherine Tugusheva

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Rachel Korn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Tanesha Cash-Mason

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Jill W Maxwell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Nathan G Hatcher

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sharie J Haugabook

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Guoxin Wu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Bonnie J Howell

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

John J Renger

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Paul J Shughrue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Alexander McCampbell

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

1 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

2884-2897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation

8 March 2020

cites work

1 reference

12 December 2020

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

1 reference

12 December 2020

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

1 reference

12 December 2020

Self-assembly of Abeta(1-42) into globular neurotoxins.

1 reference

12 December 2020

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

1 reference

12 December 2020

Rapid photochemical cross-linking--a new tool for studies of metastable, amyloidogenic protein assemblies

1 reference

12 December 2020

Alzheimer's beta-peptide oligomer formation at physiologic concentrations

1 reference

12 December 2020

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

1 reference

12 December 2020

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

1 reference

12 December 2020

Amyloid beta-protein: monomer structure and early aggregation states of Abeta42 and its Pro19 alloform.

1 reference

12 December 2020

Preparation of aggregate-free, low molecular weight amyloid-beta for assembly and toxicity assays.

1 reference

12 December 2020

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease

1 reference

12 December 2020

Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid Peptides

1 reference

12 December 2020

A specific amyloid-beta protein assembly in the brain impairs memory

1 reference

12 December 2020

Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.

1 reference

12 December 2020

Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry

1 reference

12 December 2020

A ganglioside-induced toxic soluble Abeta assembly. Its enhanced formation from Abeta bearing the Arctic mutation

1 reference

12 December 2020

Solution state characterization of amyloid beta-derived diffusible ligands

1 reference

12 December 2020

Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.

1 reference

12 December 2020

Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.

1 reference

12 December 2020

Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

1 reference

12 December 2020

Ultrasensitive flow-based immunoassays using single-molecule counting

1 reference

12 December 2020

Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons

1 reference

12 December 2020

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

1 reference

12 December 2020

Detecting dementia with the mini-mental state examination in highly educated individuals

1 reference

12 December 2020

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

1 reference

12 December 2020

Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology

1 reference

12 December 2020

First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates

1 reference

12 December 2020

A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease

1 reference

12 December 2020

Targeting generation of antibodies specific to conformational epitopes of amyloid beta-derived neurotoxins

1 reference

12 December 2020

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

12 December 2020

A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain

1 reference

12 December 2020

Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction

1 reference

12 December 2020

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

12 December 2020

Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease

1 reference

12 December 2020

High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

1 reference

12 December 2020

The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia.

1 reference

12 December 2020

In-office mental status testing: a practical guide.

1 reference

12 December 2020

Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease

1 reference

12 December 2020

Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers

1 reference

12 December 2020

Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20

1 reference

12 December 2020

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

1 reference

12 December 2020

Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease

1 reference

12 December 2020

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

1 reference

12 December 2020

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease

1 reference

12 December 2020

Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites

1 reference

12 December 2020

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

1 reference

12 December 2020

Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects.

1 reference

12 December 2020

Effect of human cerebrospinal fluid sampling frequency on amyloid-β levels.

1 reference

12 December 2020

Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease.

1 reference

12 December 2020

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

1 reference

12 December 2020

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

1 reference

12 December 2020

Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes

1 reference

12 December 2020

Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β

1 reference

12 December 2020

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

1 reference

12 December 2020

The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients.

1 reference

12 December 2020

Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?

1 reference

12 December 2020

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study

1 reference

12 December 2020

Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue.

1 reference

12 December 2020

A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.

1 reference

12 December 2020

Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls

1 reference

12 December 2020

New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.

1 reference

12 December 2020

Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults

1 reference

12 December 2020

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

1 reference

12 December 2020

A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid

1 reference

12 December 2020

Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

12 December 2020

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

12 December 2020

Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy.

1 reference

12 December 2020

10.1523/JNEUROSCI.1675-13.2014

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24553930%20AND%20SRC:MED&resulttype=core&format=json